0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 06285368 2024-04-01 2025-03-31 06285368 2025-03-31 06285368 2024-03-31 06285368 2023-04-01 2024-03-31 06285368 2024-03-31 06285368 2023-03-31 06285368 core:MotorVehicles 2024-04-01 2025-03-31 06285368 bus:Director1 2024-04-01 2025-03-31 06285368 core:MotorVehicles 2024-03-31 06285368 core:MotorVehicles 2025-03-31 06285368 core:WithinOneYear 2025-03-31 06285368 core:WithinOneYear 2024-03-31 06285368 core:ShareCapital 2025-03-31 06285368 core:ShareCapital 2024-03-31 06285368 core:RetainedEarningsAccumulatedLosses 2025-03-31 06285368 core:RetainedEarningsAccumulatedLosses 2024-03-31 06285368 core:MotorVehicles 2024-03-31 06285368 bus:SmallEntities 2024-04-01 2025-03-31 06285368 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 06285368 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 06285368 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06285368 bus:FullAccounts 2024-04-01 2025-03-31 06285368 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 06285368 core:OtherPropertyPlantEquipment 2024-03-31 06285368 core:OtherPropertyPlantEquipment 2025-03-31
COMPANY REGISTRATION NUMBER: 06285368

J.Lim Surgery Limited

Filleted Unaudited Financial Statements

31 March 2025

J.Lim Surgery Limited

Financial Statements

Year ended 31 March 2025

Contents | Pages

Balance sheet | 1 to 2

Notes to the financial statements | 3 to 5

J.Lim Surgery Limited

Balance Sheet

31 March 2025

| 2025 | 2024
Note | £ | £

Fixed assets

Tangible assets | 4 | 27,670 | 36,695

Current assets

Debtors | 5 | 37,600 | 105,511
Cash at bank and in hand | 457,162 | 358,933
| --------- | ---------
| 494,762 | 464,444

Creditors: amounts falling due within one year | 6 | 85,365 | 54,591
| --------- | ---------
Net current assets | 409,397 | 409,853
| --------- | ---------
Total assets less current liabilities | 437,067 | 446,548

Provisions | 6,918 | 9,170
| --------- | ---------
Net assets | 430,149 | 437,378
| --------- | ---------

Capital and reserves

Called up share capital | 4 | 4
Profit and loss account | 430,145 | 437,374
| --------- | ---------
Shareholders funds | 430,149 | 437,378
| --------- | ---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

J.Lim Surgery Limited

Balance Sheet (continued)

31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 2 November 2025 , and are signed on behalf of the board by:

Mr J T K Lim
Director

Company registration number: 06285368

J.Lim Surgery Limited

Notes to the Financial Statements

Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Minnie Farm, Red Hall Lane, Halmer End, Stoke on Trent, ST7 8AX.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest £.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Motor vehicles | - | 25% reducing balance
| Equipment | - | 25% reducing balance

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. The basic financial instruments of the company are as follows: Debtors Debtors do not carry any interest and are stated at their nominal value. Appropriate allowances for estimated irrecoverable amounts are recognised in the Profit and Loss account when there is objective evidence that the asset is impaired. Cash at bank and in hand This comprises cash at bank and in hand. Trade creditors Trade creditors are not interest bearing and are stated at their nominal value.
4. Tangible assets

| Motor vehicles | Equipment | Total
| £ | £ | £
Cost |  |  |
At 1 April 2024 | 60,190 | 7,584 | 67,774
Additions | – | 199 | 199
| -------- | ------- | --------
At 31 March 2025 | 60,190 | 7,783 | 67,973
| -------- | ------- | --------
Depreciation |  |  |
At 1 April 2024 | 26,333 | 4,746 | 31,079
Charge for the year | 8,464 | 760 | 9,224
| -------- | ------- | --------
At 31 March 2025 | 34,797 | 5,506 | 40,303
| -------- | ------- | --------
Carrying amount |  |  |
At 31 March 2025 | 25,393 | 2,277 | 27,670
| -------- | ------- | --------
At 31 March 2024 | 33,857 | 2,838 | 36,695
| -------- | ------- | --------

5. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 28,648 | 38,198
Other debtors | 8,952 | 67,313
| -------- | ---------
| 37,600 | 105,511
| -------- | ---------

6. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Corporation tax | 43,225 | 53,218
Other creditors | 42,140 | 1,373
| -------- | --------
| 85,365 | 54,591
| -------- | --------

7. Directors' advances, credits and guarantees